AnchorMesh
Resilient Anchoring Implants for Arthroscopic Orthopedic Fixation
Company Overview
Snapshot
Founded in June 2021 by Tamir Ben David, AnchorMesh operates with 1–10 employees. The company has secured funding across one round from Israel Innovation Authority. In December 2024, AnchorMesh received a grant from the Israel Innovation Authority, signaling early validation for its orthopedic fixation technology.
Business overview
AnchorMesh develops a single, cost-effective fixation technology anchor platform designed for a wide range of orthopedic procedures in soft cancellous bone. The company's implant design focuses on maximizing fixation contact area within the bone while preserving bone integrity and supporting arthroscopic workflow. Operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Assistive Devices, AnchorMesh serves the healthcare market, targeting both providers and patients.
Log in to access full profile ›Company Intelligence Q&A
- What is AnchorMesh's core product?
- AnchorMesh offers a single, cost-effective fixation technology anchor platform designed to address a wide range of orthopedic procedures in soft cancellous bone, maximizing fixation contact area while preserving bone integrity.
- When was AnchorMesh founded?
- AnchorMesh was founded in June 2021.
- Who is a co-founder of AnchorMesh?
- Tamir Ben David is a co-founder of AnchorMesh.
- Which organization provided a grant to AnchorMesh?
- In December 2024, AnchorMesh received a grant from the Israel Innovation Authority.
- What is the current product stage of AnchorMesh?
- AnchorMesh's product is currently in the R&D stage, as indicated by its Pre-Seed funding stage and the nature of its grant from the Israel Innovation Authority in December 2024, which often supports early-stage technological development.